GAST and type 1 diabetes mellitus: However, improved glucose control and neogenesis of functional β‐cell mass have been shown with gastrin treatment,[18, 19, 20, 21, 22, 23] suggesting that Gastrin‐SiO2 microspheres may also have a beneficial effect on type 1 diabetes (T1D), via the gut‐pancreas axis.